Mycoplasma Pneumonia

Written by Lydia Krause | Published on July 16, 2012
Medically Reviewed by Peter Rudd, MD

Mycoplasma Pneumonia

Mycoplasma pneumonia (MP) is a contagious respiratory infection. Every year almost 2 million Americans are treated for MP. The disease is easily spread through contact with respiratory fluids, and it causes regular epidemics.

The most common sign of infection is a dry cough. Untreated or severe cases can have symptoms affecting the heart and nervous system. In rare cases, MP can be fatal.

Diagnosis is difficult in the early stages of MP because there are few unusual symptoms. As the disease progresses, it can be detected through imaging and laboratory tests. Antibiotics are used to treat MP. Cases unresponsive to antibiotics may need to be treated with intravenous medications.

What Causes Mycoplasma Pneumonia?

MP is caused by a bacterium called Mycoplasma pneumoniae. This is the most recognized of all human pathogens—there are over 200 different known species. Most patients with respiratory infection due to M. pneumoniae do not develop pneumonia. Once inside the body, the bacterium may attach itself to lung tissue and multiply until a full infection develops. Most cases are mild and self-limited.

Risk Factors for Developing Mycoplasma Pneumonia

In many healthy adults, the immune system is capable of fighting off MP before it can grow into an infection. Those who are most at risk include:

  • elderly people
  • people who have immune-compromising diseases (e.g. HIV)
  • people who have lung disease
  • people who have sickle cell disease
  • children younger than age 5

What Are the Symptoms of Mycoplasma Pneumonia?

The symptoms of MP are those of a common upper respiratory tract infection.

Common symptoms of MP include:

  • persistent fever
  • dry cough
  • malaise
  • fever

In rare cases, the infection may become dangerous and cause damage to the heart or central nervous system. Examples of these disorders include:

  • arthritis (disorder in which the joints become inflamed)
  • pericarditis (inflammation of the pericardium that surrounds the heart)
  • Guillain-Barré syndrome (neurological disorder that can lead to paralysis and death)
  • encephalitis (inflammation of the brain)

How Does Your Doctor Diagnose Mycobacteria Pneumonia?

The disease incubates (silently develops) for the first one to three weeks after exposure. Diagnosis is difficult in the early stages because the body does not instantly reveal an infection. Sometimes manifestations of infection may occur outside the lung. In these cases, signs of infection may include break up of red blood cells, skin rash, joint involvement, and symptoms and signs that indicate of gastrointestinal tract, central nervous system, and heart disease. Three to seven days after the first symptoms appear, medical testing can show evidence of an MP infection.

Tests for the presence of MP include:

  • listening to breathing with a stethoscope for abnormalities
  • chest X-ray (CXR)
  • computed tomography (CT) scan

Although final results may require days or weeks, laboratory tests for MP include:

Treatment Options for Mycobacteria Pneumonia

Antibiotics

MP is a bacterial infection the first line of treatment is antibiotics. Antibiotics must differ for children to avoid any potentially dangerous side effects.

Macrolides, the first choice of antibiotics for children, include:

  • erythromycin
  • clarithromycin
  • roxithromycin
  • azithromycin

Antibiotics prescribed for adults include:

  • doxycycline
  • tetracycline
  • quinolones

Corticosteroids

Not all people respond to antibiotic treatment. Treatment for those who are unresponsive to antibiotics or complications of illness include corticosteroids:

  • prednisolone
  • methylprednisone

Immunomodulatory Therapy

Severe cases of MP are treated with an immunomodulatory therapy plus antibiotics. An immunomodulatory therapy boosts or decreases the effects of whatever type of medicine it is taken with. Examples of immunomodulatory medication plus antibiotics include:

  • corticosteroids with antibiotics
  • intravenous Ig (IVIg) plus antibiotics

The Long-Term Outlook After Mycoplasma Pneumonia

After treatment most symptoms should subside quickly. Patients can expect a cough to remain the longest. Within two to four weeks, most cases are resolved with no lasting consequences.

People with weak immune systems or chronic infections may struggle to fight off an MP infection. According to the Centers for Disease Control and Prevention (CDC), each year more than 100,000 people in the United States are hospitalized for MP. In some cases, complications develop that can prove fatal (CDC, 2005).

Tips to Prevent Mycoplasma Pneumonia

MP peaks in the fall and winter months. During these times, the risk of contracting MP is greatest. This is especially true in schools, daycare centers, and dorms. Close places make it easy for the infection to transmit from person to person.

Here are some tips to lower your risk of infection:

  • getting six to eight hours of sleep a night
  • eating a balanced diet
  • staying away from those who have symptoms of MP
  • washing hands before eating or after interacting with sick contacts
Was this article helpful? Yes No

Thank you.

Your message has been sent.

We're sorry, an error occurred.

We are unable to collect your feedback at this time. However, your feedback is important to us. Please try again later.

Article Sources:

  • Ansarin, K., Abedi, S., Ghotaslou, R., Soroush, M., Ghabili, K., & Chapman, K. (2011). Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction. International Journal of General Medicine, 4, 1-4.
  • CDC (2005). Mycoplasma pneumoniae. Centers for Disease Control and Prevention. Retrieved July 2012, from http://www.cdc.gov/ncidod/dbmd/diseaseinfo/mycoplasmapneum_t.htm
  • Nagashima, M., Higaki, T., Satoh, H., & Nakano, T. (2012). Cardiac thrombus associated with Mycoplasma pneumoniae infection. Interactive CardioVascular and Thoracic Surgery, 11(6), 849-851.
  • Youn, Y., & Lee, K. (2012). Mycoplasma pneumonia in children. Korean Journal Pediatrics, 55(2), 42-47.

More on Healthline

Lifestyle Changes to Help Manage COPD
Lifestyle Changes to Help Manage COPD
Leading a healthy lifestyle can make a big difference in your COPD symptoms. Learn more about basic changes that will make it easier to manage your COPD.
Beyond Back Pain: 5 Warning Signs of Ankylosing Spondylitis
Beyond Back Pain: 5 Warning Signs of Ankylosing Spondylitis
There are a number of potential causes of back pain, but one you might not know about is ankylosing spondylitis (AS). Find out five warning signs of AS in this slideshow.
Easy Ways to Conceal an Epinephrine Shot
Easy Ways to Conceal an Epinephrine Shot
Learn how to discreetly carry your epinephrine autoinjectors safely and discreetly. It’s easier than you think to keep your shots on hand when you’re on the go.
Common Asthma Triggers and How to Avoid Them
Common Asthma Triggers and How to Avoid Them
Learn about some of the most common triggers for asthma, as well as measures you can take to minimize your risk of exposure, symptoms, and flares.
The Best Multiple Sclerosis iPhone and Android Apps of the Year
The Best Multiple Sclerosis iPhone and Android Apps of the Year
These best multiple sclerosis apps provide helpful information and tools to keep track of your symptoms, including medication reminders.
Advertisement
Advertisement
Advertisement